Clinical Trial Update: A Study of Apatinib in Non-triple-negative Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated apatinib in non-triple-negative metastatic breast cancer and the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Fudan University | Conditions: Breast Neoplasms | Phase 2 | Status: COMPLETED